IARC MONOGRAPHS ON THE EVALUATION OF CARCINOGENIC ...

120
IARC MONOGRAPHS VOLUME 82
Che, C.-T., Ahmed, M.S., Kang, S.S., Waller, D.P., Bingel, A.S., Martin, A., Rajamahendran, P.,
Bunyapraphatsara, N., Lankin, D.C., Cordell, G.A., Soejarto, D.D., Wijesekera, R.O.B. &
Fong, H.H.S. (1984) Studies on Aristolochia. III. Isolation and biological evaluation of constituents
of Aristolochia indica roots for fertility-regulating activity. J. nat. Prod., 47, 331–341
Chinese Materia Medica (1995) Safety, Efficacy and Modernization, Beijing, China Academy of
Trade
Commission of the Ministry of Public Health (2000) Pharmacopoeia (Part I), Beijing, Chemical
Industry Press, pp. 31, 39, 41, 114, 154
Cory, R.M., Chan, D.M.T., McLaren, F.R., Rasmussen, M.H. & Renneboog, R.M. (1979) A short
synthesis of ishwarone. Tetrahedron Lett., 43, 4133–4136 [consulted as abstract:
CA1980:215559]
Cosyns, J.-P., Jadoul, M., Squifflet, J.P., de Plaen, J.F., Ferluga, D. & Van Ypersele de Strihou, C.
(1994a) Chinese herbs nepropathy: A clue to Balkan endemic nephropathy? Kidney int., 45,
1680–1688
Cosyns, J.-P., Jadoul, M., Squifflet, J.P., Van Cangh, P.J. & Van Ypersele de Strihou, C. (1994b)
Urothelial malignancy in nephropathy due to Chinese herbs (Letter to the Editor). Lancet,
344, 188
Cosyns, J.-P., Jadoul, M., Squifflet, J.P., Wese, F.X. & Van Ypersele de Strihou, C. (1999) Urothelial
lesions in Chinese herb nephropathy. Am. J. Kidney Dis., 33, 1011–1017
Cosyns, J.-P., Dehoux, J.-P., Guiot, Y., Goebbels, R.-M., Robert, A., Bernard, A.M. & Van
Ypersele de Strihou, C. (2001) Chronic aristolochic acid toxicity in rabbits: A model of
Chinese herbs nephropathy? Kidney int., 59, 2164–2173
Debelle, F.D., Nortier, J.L., De Prez, E.G., Garber, C.H., Vienne, A.R., Salmon, I.J., Deschodt-
Lanckman, M.M. & Vanherweghem, J.L. (2002) Aristolochic acids induce chronic renal
failure with interstitial fibrosis in salt-depleted rats. J. Am. Soc. Nephrol., 13, 431–436
Depierreux, M., Van Damme, B., Vanden Houte, K. & Vanherweghem, J.-L. (1994) Pathologic
aspects of a newly described nephropathy related to the prolonged use of Chinese herbs. Am.
J. Kidney Dis., 24, 172–180
EMEA (European Agency for the Evaluation of Medicinal Products) (2000) Working Party on
Herbal Medicinal Products: Position paper on the risks associated with the use of herbal
products containing Aristolochia species (EMEA/HMPWP/23/00), London
European Commission (2000) Twenty-fifth Commission Directive 2000/11/EC of 10 March 2000
adapting to technical progress Annex II to Council Directive 76/768/EEC on the approximation
of the laws of the Member States relating to cosmetic products. Off. J., L065
von Euw, J., Reichstein, T. & Rothschild, M. (1968) Aristolochic acid-I in the swallowtail
butterfly Pachlioptera aristolochiae (Fabr.) (Papilionidae). Israel J. Chem., 6, 659-670
Fernando, R.C., Schmeiser, H.H., Nicklas, W. & Wiessler, M. (1992) Detection and quantitation
of dG-AAI and dA-AAI adducts by 32 P-postlabelling methods in urothelium and exfoliated
cells in urine of rats treated with aristolochic acid I. Carcinogenesis, 13, 1835–1839
Fernando, R.C., Schmeiser, H.H., Scherf, H.R. & Wiessler, M. (1993) Formation and persistence
of specific purine DNA adducts by 32 P-postlabelling in target and non-target organs of rats
treated with aristolochic acid I. In: Phillips, D.H., Castegnaro, M. & Bartsch, H., eds, Postlabelling
Methods for Detection of DNA Adducts (IARC Scientific Publications No. 124),
IARCPress, Lyon, pp. 167–171